Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
Recent trials of intensive glycemic control suggest a possible link between hypoglycemia and excess cardiovascular mortality in patients with type 2 diabetes. Hypoglycemia might cause arrhythmias through effects on cardiac repolarization and changes in cardiac autonomic activity. Our aim was to study the risk of arrhythmias during spontaneous hypoglycemia in type 2 diabetic patients with cardiovascular risk. Twenty-five insulin-treated patients with type 2 diabetes and a history of cardiovascular disease or two or more risk factors underwent simultaneous continuous interstitial glucose and ambulatory electrocardiogram monitoring. Frequency of arrhythmias, heart rate variability, and markers of cardiac repolarization were compared between hypoglycemia and euglycemia and between hyperglycemia and euglycemia matched for time of day. There were 134 h of recording at hypoglycemia, 65 h at hyperglycemia, and 1,258 h at euglycemia. Bradycardia and atrial and ventricular ectopic counts were significantly higher during nocturnal hypoglycemia compared with euglycemia. Arrhythmias were more frequent during nocturnal versus daytime hypoglycemia. Excessive compensatory vagal activation after the counterregulatory phase may account for bradycardia and associated arrhythmias. QT intervals, corrected for heart rate, >500 ms and abnormal T-wave morphology were observed during hypoglycemia in some participants. Hypoglycemia, frequently asymptomatic and prolonged, may increase the risk of arrhythmias in patients with type 2 diabetes and high cardiovascular risk. This is a plausible mechanism that could contribute to increased cardiovascular mortality during intensive glycemic therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational reports in individuals with diabetes undergoing continuous glucose and electrocardiogram (ECG) monitoring have noted an increased prevalence of arrhythmias during periods of hypoglycemia as compared to euglycemia (5, 6).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [5]
In the citing paper
“They can also be vulnerable to irregular heartbeat, which can be life-threatening45.”
From A wearable patch for continuous analysis of thermoregulatory sweat at rest (2021) · cites this paper as [45]
In the citing paper
“In contrast, patients with diabetes may have a lower risk of inappropriate therapy or ICD shock, since they may be more sedentary with consequently less frequent exercise-induced sinus tachycardia and also lower incidence of lead fracture.600,658,659”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [658]
In the citing paper
“Observational studies have reported significant corrected QT (QTc) interval prolongation possibly associated with microvascular complications, atypical patterns of microvolt T-wave alternans, altered heart rate variability, or heart rate turbulence in patients with diabetes, but none of these tests should routinely be used to stratify the risk of ventricular arrhythmias or SCD in clinical practice”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [658]
Citations
Cites
Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use
Electrophysiology, T. F. O. T. E. S. O. C. T. N. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.1043 · Cited by 17,159
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., & Schwartz, P. J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014868 · Cited by 15,289
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“Intensive glycemic control for between 3 and 5 years did not reduce cardiovascular mortality in recent trials (2,3) and the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was terminated early owing to increased mortality in patients with type 2 diabetes at high cardiovascular risk (4).”
BackgroundTesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Cardiac Electrophysiology: From Cell to Bedside
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-12-1069_5 · Cited by 2,385
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Self-citationDiagnosis and management of diabetic autonomic neuropathy.
Ewing, D. J., & Clarke, B. F. (1982) · BMJ · doi:10.1136/bmj.285.6346.916 · Cited by 1,235
Montano, N., Ruscone, T. G., Porta, A., Lombardi, F., Pagani, M., & Malliani, A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1826 · Cited by 1,108
Cited by
Items 201–300 of 402
Blood electrolyte disturbances during severe hypoglycemia in Korean patients with type 2 diabetes
Kang, M. Y. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.5.648 · Cited by 12
“A plausible mechanism of increased cardiovascular mortality during severe hypoglycemia might be associated with fatal arrhythmias induced during hypoglycemia [5].”
BackgroundUniversal structures of normal and pathological heart rate variability
Gañán‐Calvo, A. M., & Fajardo-López, J. (2016) · Scientific Reports · doi:10.1038/srep21749 · Cited by 12
Ashrafi, R. A., Ahola, A. J., Rosengård‐Bärlund, M., Saarinen, T., Heinonen, S., Juuti, A., Marttinen, P., & Pietiläinen, K. H. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1964035 · Cited by 16
Mongraw‐Chaffin, M., Beavers, D. P., & McClain, D. A. (2019) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2019.100202 · Cited by 12
Enhancing Generalization in Arrhythmia Classification with Attention MechanismsPreprint
Huang, Z.-J., MacLachlan, S., Truong, N. D., & Kavehei, O. (2023) · medRxiv · doi:10.1101/2023.07.05.23292238 · Cited by 2
“The incidence of arrhythmias tends to increase with age and is also influenced by other factors such as hypertension, diabetes, and pre-existing heart disease [5] [8].”
BackgroundUse of Continuous Glucose Monitoring in Patients Following Bariatric Surgery: A Scoping Review
Yu, Y. H., & Groth, S. W. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06704-1 · Cited by 12
Lucci, C., Marongiu, A., Genovese, S., Mazza, M., Cosentino, N., & Marenzi, G. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02862-x · Cited by 12
Oh, P. C., Eom, Y. S., Moon, J., Jang, H., Kim, T., Suh, J., Kong, M. G., Park, S., Kwon, S. W., Suh, S. Y., et al. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01777-7 · Cited by 11
Wang, J., Lo, S., Yeh, Y., Hwu, C., Huang, C., Hsieh, C., & Sheu, W. H. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14410 · Cited by 12
Saito, K., Okada, Y., Torimoto, K., Takamatsu, Y., & Tanaka, Y. (2021) · Sleep And Breathing · doi:10.1007/s11325-021-02442-9 · Cited by 11
Glycaemia and cardiac arrhythmias in people with type 1 diabetes: A prospective observational study
Hagelqvist, P. G., Andersen, A., Maytham, K. B., Andreasen, C. R., Engberg, S., Lindhardt, T. B., Forman, J. L., Pedersen‐Bjergaard, U., Knop, F. K., & Vilsbøll, T. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15108 · Cited by 12
Hoogwerf, B. J., Lincoff, A. M., Rodríguez, Á., Chen, L., & Qu, Y. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0393-6 · Cited by 10
Reiff, S., & Fava, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.014 · Cited by 10
Hypoglycemic cardiac arrest and rapid return-of-spontaneous circulation (ROSC) with dextrose
Fun, J. R. S., & Chia, M. Y. C. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.05.025 · Cited by 10
Bernjak, A., Novodvorský, P., Chow, E., Iqbal, A., Sellors, L., Williams, S., Fawdry, R. A., Marques, J. L. B., Jacques, R., Campbell, M. J., et al. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101237 · Cited by 11
Self-citationMatsushita, Y., Takata, Y., Kawamura, R., Takakado, M., Hadate, T., & Osawa, H. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.04.029 · Cited by 10
Uanini, N. (2001) · Anuario del Centro de Estudios Históricos "Prof. Carlos S. A. Segreti" · Cited by 10
Roberts, G. W., Krinsley, J. S., Preiser, J., Quinn, S. J., Rule, P. R., Brownlee, M., Umpierrez, G. E., & Hirsch, I. B. (2024) · Journal of Critical Care · doi:10.1016/j.jcrc.2024.154537 · Cited by 10
Effect of Cardiac Resynchronization Therapy in Patients With Insulin-Treated Diabetes Mellitus
Szepietowska, B., Kutyifa, V., Ruwald, M. H., Solomon, S. D., Ruwald, A., McNitt, S. A., Polonsky, B., Thomas, S., Moss, A. J., & Zaręba, W. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.04.053 · Cited by 9
Recognizing and minimizing hypoglycemia: The need for individualized care
Lavernia, F., Kushner, P. R., Trence, D., Rice, D., DAILEY, G. E., & Kuritzky, L. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1086628 · Cited by 11
“bradycardia, atrial ectopic activity) [10].”
Mitsuishi, S., Nishimura, R., Ando, K., Tsujino, D., & Utsunomiya, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144041 · Cited by 9
Jang, H., Oh, P. C., Moon, J., Suh, J., Park, H. W., Park, S., Lee, K., Kim, J. S., Lee, H., Choi, R. K., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.01.006 · Cited by 10
Mylona, M., Liatis, S., Anastasiadis, G., Kapelios, C. J., & Kokkinos, A. D. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108038 · Cited by 10
Ling, J., Poon, E. W. M., Yang, A., Yeung, T., Loo, K.-M., Ozaki, R., Ronald, C. W., Luk, A. O. Y., Kong, A. P. S., Chan, J. C. N., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01046-6 · Cited by 9
Self-citationEarly Morning QT Prolongation During Hypoglycemia: Only a Matter of Glucose?
D’Imperio, S., Monasky, M. M., Micaglio, E., Negro, G., & Pappone, C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.688875 · Cited by 9
Glibenclamide Prevents Hypoglycemia-Induced Fatal Cardiac Arrhythmias in Rats
Reno, C. M., Bayles, J., Skinner, A., & Fisher, S. J. (2018) · Endocrinology · doi:10.1210/en.2018-00419 · Cited by 9
Understanding the cardiovascular risk with non-insulin antidiabetic drugs
Athyros, V. G., Imprialos, K. P., Stavropoulos, K., Sahinidis, A., & Doumas, M. N. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1586881 · Cited by 10
Sleep as a window of cardiometabolic health: The potential of digital sleep and circadian biomarkers
van den Brink, W. J., Oosterman, J. E., Smid, D. J., de Vries, H., Atsma, D. E., Overeem, S., & Wopereis, S. (2025) · Digital Health · doi:10.1177/20552076241288724 · Cited by 12
Hypoglycaemia, Abnormal Lipids, and Cardiovascular Disease among Chinese with Type 2 Diabetes
Li, Y., Mu, Y., Ji, Q., Huang, Q., Kuang, H., Ji, L., & Yang, X. (2015) · BioMed Research International · doi:10.1155/2015/862896 · Cited by 10
Ghosal, S., Sinha, B., & Gangopadhyay, K. K. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.01.013 · Cited by 9
Can hypoglycemic episodes in type 1 diabetics trigger cardiac arrhythmias?
Lainetti, K. R., Pimenta, J., & Vendramini, M. F. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107878 · Cited by 11
Shahreyar, M., Muppidi, V., Choudhuri, I., Sra, J. S., Tajik, A. J., & Jahangir, A. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1059276 · Cited by 10
“%) for secondary prevention of SCD, was described.”
BackgroundInfluentialAnfinogenova, Y., Grakova, E. V., Shvedova, M., Kopeva, K. V., Teplyakov, A. T., & Popov, S. V. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9647-y · Cited by 8
Xu, J., Zhou, H., & Wang, Z. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02931-1 · Cited by 8
Farahani, P. (2018) · International Journal of Endocrinology · doi:10.1155/2018/3718958 · Cited by 9
“These have been illustrated in a clinical study where patients with type 2 diabetes simultaneously utilized outpatient Holter monitors and continuous interstitial glucose monitors (CGM) [37].”
BackgroundZhang, Y., Han, Y., Gao, P., Mo, Y., Hao, S., Huang, J., Ye, F., Li, Z., Zheng, L., Yao, X., et al. (2021) · JMIR Medical Informatics · doi:10.2196/23606 · Cited by 8
“Studies have shown that conditions with asymptomatic and persistent hypoglycemia increased the risk of arrhythmia [33].”
BackgroundKubota, T., Yubakami, M., Ushigome, E., Ohashi, T., Shoda, K., Konishi, H., Shiozaki, A., Fujiwara, H., Okamoto, K. K., Fukui, M., et al. (2022) · Annals of Surgery Open · doi:10.1097/as9.0000000000000135 · Cited by 10
IoT and Machine Learning-Based Hypoglycemia Detection System
Sifat, F. H., Mahzabin, R., Anjum, S., Nayan, A.-A., & Kibria, M. G. (2022) · International Conference on Innovations in Science, Engineering and Technology (ICISET) · doi:10.1109/iciset54810.2022.9775890 · Cited by 7
Lee, Y., Bae, Y., Kim, H., Park, J., Kwon, S. Y., Park, S., Kim, G., Hur, K. Y., Kim, J. H., & Jin, S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110083 · Cited by 7
Depressed HCN4 function in the type 2 diabetic sinoatrial node
Parveen, S., Cheah, P. H. S., Worthington, L. P. I., Smither, R. A., Munro, M. L., Bussey, C. T., Lamberts, R. R., & Jones, P. P. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04635-6 · Cited by 7
Huang, H., Liu, P. P., Lin, S., Yeh, J., Hsu, J., Peng, C. C., Munir, K. M., Loh, C., & Tu, Y. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad038 · Cited by 7
Corchuelo, J. C., Guerrero‐Pérez, F., de la Jordana, P. G.-S., & Pérez-Maraver, M. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.06.013 · Cited by 8
“Tratamiento sustitutivo renal, n (%) 10 (6,8) 1 (4,2) 9 (7,4) NS”
InfluentialKofod, D. H., Diederichsen, S. Z., Bomholt, T., Andersen, M. Ø., Andersen, A., Mannheimer, E. E., Rix, M., Liem, Y. S., Lindhard, K., Hansen, H. P., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06388-5 · Cited by 7
“Furthermore, an association has been found between nocturnal hypogly-caemia and bradycardia in two studies employing 4–5 days of simultaneous Holter monitoring and continuous glucose monitoring (CGM) in individuals with type 1 and type 2 diabetes [9, 10].”
Gardner, D. S.-L., Tan, H. C., Lim, G. H., Oo, M. Z., Xin, X., & CHANDRAN, S. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-47351-x · Cited by 9
Takahashi, H., Nishimura, R., Onda, Y., Ando, K., Tsujino, D., & Utsunomiya, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177283 · Cited by 7
Effect of Isolated Obesity on Left Ventricular Function and Structure: A Single-Center Experience
Alrahimi, J. S., Aboud, A., AlQuhaibi, A. S., Almaghrabi, Y., Alghamdi, Y. S., & Mufti, H. N. (2021) · Cureus · doi:10.7759/cureus.13988 · Cited by 7
“Many studies demonstrated this association among patients with other comorbidities [9-11], however, few studies focused on the isolated risk of obesity [8,12].”
BackgroundIDegAsp (insulin degludec + insulin aspart) for the management of type 2 diabetes: current status
Christiansen, J. S., Home, P., & Kumar, A. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2016.1145541 · Cited by 6
“ciated) [19], mechanistic evidence continues to suggest the possibility of such a role [20].”
BackgroundKaplan, H., Amod, A., Zyl, F. H. V., Reddy, J., van Tonder, A., Tsymbal, E., & McMaster, A. (2019) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2019.1608053 · Cited by 6
Pedrosa, H. C., Braver, J. D., Rolim, L. C., Schmid, H., Calsolari, M. R., & Odriozola, A. (2019) · Alad · doi:10.24875/alad.18000352 · Cited by 6
Guo, F.-S., Dou, J., Wang, J.-X., Guo, C. Y., Wu, R., Sun, X.-L., Hu, Y.-W., & Wei, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01671-2 · Cited by 6
“…identifies higher risk of death in participants with low SHR, which may be explained by mechanisms such as cardiac arrhythmias (including prolonged QT intervals, cardiac repolarization abnormalities, and increased ectopic rhythms), impaired cardiac autonomic function, and other factors [57–59].”
Lin, Y. K., Aikens, J. E., de Zoysa, N., Hall, D., Funnell, M. M., Nwankwo, R. B., Kloss, K., DeJonckheere, M. J., Pop‐Busui, R., Piatt, G., et al. (2023) · JMIR Formative Research · doi:10.2196/50374 · Cited by 5
“Hypoglycemia episodes, especially those with blood glucose 54 mg/dL, can cause acute problems including brain dysfunction [1,2] and cardiac arrhythmias [3].”
BackgroundPositionspapier Herzinsuffizienz und Diabetes
Schütt, K. S., Aberle, J., Bauersachs, J. K., Birkenfeld, A. L., Frantz, S., Ganz, M., Jacob, S., Kellerer, M., Leschke, M., Liebetrau, C., et al. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1867-3026 · Cited by 6
Ma, S., ALVEAR, A. C., Schreiner, P. J., Seaquist, E. R., Kirsh, T., & Chow, L. S. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231184497 · Cited by 5
“18 In addition, many previously reported risk models were derived based on a mixed population that also includes patients with type 1 diabetes mellitus (T1DM).”
Brain Regulation of Cardiac Function during Hypoglycemia
Chambers, M. E., Nuibe, E. H., & Reno, C. M. (2023) · Metabolites · doi:10.3390/metabo13101089 · Cited by 7
“The post-ganglionic neurons are cholinergic and 2 3 2 2 by decreasing In the brain, most mammalian post-ganglionic act during hypoglycemic events . on the heart [81,82].”
BackgroundResultInfluentialKofod, D. H., Diederichsen, S. Z., Bomholt, T., Andersen, M. Ø., Rix, M., Liem, Y. S., Lindhard, K., Hansen, H. P., Rydahl, C., Lindhardt, M. K., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-077063 · Cited by 5
Yoneda, C., Tashima-Horie, K., Fukushima, S., Saito, S., Tanaka, S., Haruki, T., Ogino, J., Suzuki, Y., & Hashimoto, N. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej15-0647 · Cited by 5
The clinical impact of hypoglycemia in hospitalized patients
Borzì, V., & Fontanella, A. (2015) · Italian Journal of Medicine · doi:10.4081/itjm.2015.549 · Cited by 6
Lim, W., Goh, S., Bee, Y. M., Chan, T. C. E., Tan, X. H. A., Wee, Z., Xin, X., Ang, L. C., Heng, W. M., & Teh, M. M. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1528213 · Cited by 5
Management of Diabetes Mellitus
Jenkins, A. J., SCOTT, E. S., Fulcher, J., Kilov, G., & Januszewski, A. S. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_7 · Cited by 6
Diabetes im Alter: HbA1c und wie weiter?
Zeyfang, A. (2018) · Diabetes aktuell · doi:10.1055/a-0664-7269 · Cited by 5
Wing, J., & Jivan, D. (2015) · South African Medical Journal · doi:10.7196/samj.2016.v106i1.10284 · Cited by 6
Rui, Y., Wu, B., Huang, C., & Li, Q. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1487496 · Cited by 6
“Sometimes, hypoglycemia directly affects the heart ’ s electrical activity, causing arrhythmia (27).”
Ghalati, P. F., Samadi, M. E., Verket, M., Balfanz, P., Müller‐Wieland, D., Jonas, S., Napp, A., Wanner, C., Ketteler, M., Vassiliadou, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-81983-x · Cited by 4
“In particular, Chow et al. 8 demonstrated a notable rise in the occurrence of bradyarrhythmias among T2DM individuals, while Novodvorsky et al. 21 observed a similar trend in T1DM patients.”
InfluentialGlucose Lowering Strategies for Cardiac Benefits: Pathophysiological Mechanisms
BAJAJ, H. S., & Zinman, B. (2018) · Physiology · doi:10.1152/physiol.00004.2018 · Cited by 7
“Mechanistically, hypoglycemia is associated with a number of adverse cardiovascular effects (23, 41, 51, 89).”
BackgroundHayashi, A., Matoba, K., Ohata, Y., Shimizu, N., Suzuki, A., Fujii, S., Sato, M., Takano, K., & Shichiri, M. (2022) · Renal Replacement Therapy · doi:10.1186/s41100-022-00429-0 · Cited by 7
“5 mmol/L) of sensor glucose level (SGL) of CGM in accordance with previous studies [22, 23] and a valid hypoglycemia episode as a period of SGL below threshold for over 20 min [24].”
MethodRončáková, M., Davani, A., Mikušová, V., Ságová, I., Novodvorský, P., & Martinka, E. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01440-2 · Cited by 5
Li, W., Wang, Z., Li, M., Jiang, C., Hua, C., Tang, Y., Zhang, H., Liu, X., Zheng, S., Guo, H., et al. (2025) · Heart · doi:10.1136/heartjnl-2024-324360 · Cited by 4
“29 30 Whether intensive BP therapy is beneficial or harmful in the prevention of cardiovascular events is unclear in patients having intense glycaemic management.”
An α-glucosidase inhibitor could reduce T-wave alternans in type 2 diabetes patients
Eguchi, K., Komori, T., Saito, T., Hoshide, S., & Kario, K. (2017) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2017.08.016 · Cited by 4
Shah, V. N., Rewers, A. H., & Garg, S. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00013-2 · Cited by 4
Kobayashi, S., Nagao, M., Fukuda, I., Oikawa, S., & Sugihara, H. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211010057 · Cited by 4
Mistry, S., Gouripeddi, R., Reno, C. M., Abdelrahman, S., Fisher, S. J., & Facelli, J. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284622 · Cited by 4
Zaccardi, F., Husemoen, L. L. N., Thorsted, B. L., Webb, D. R., Paul, S. K., Davies, M. J., & Khunti, K. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.01.006 · Cited by 4
“A state of controlled hypoglycaemia results in arrhythmogenic changes potentially leading to bradycardia, tachycardia, ventricular fibrillation, and sudden death (fatal arrhythmias) [3].”
BackgroundBiomarkers associated with severe hypoglycaemia and death in ACCORD
Chow, L. S., CHEN, H.-Y. P., Miller, M. E., Marcovina, S. M., & Seaquist, E. R. (2015) · Diabetic Medicine · doi:10.1111/dme.12883 · Cited by 4
Bernjak, A., Iqbal, A., Heller, S. R., & Clayton, R. H. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0612 · Cited by 5
Self-citationMario, C. D., Genovese, S., Lanza, G. A., Mannucci, E., Marenzi, G., Sciatti, E., & Pitocco, D. (2022) · Research Square · doi:10.21203/rs.3.rs-1446808/v1 · Cited by 4
Heller, S. R., & Chow, E. (2014) · Medicine · doi:10.1016/j.mpmed.2014.09.008 · Cited by 4
Self-citationNovodvorský, P., Bernjak, A., Downs, E., Smith, A., Arshad, M. F., Oprescu, A. I., Jacques, R., Lee, J., Heller, S. R., & Iqbal, A. (2025) · Diabetic Medicine · doi:10.1111/dme.70019 · Cited by 3
“8,9,20 We defined a valid hypoglycemic episode as a period of IG below the threshold for ≥ 20 min.”
Self-citationHadid, S. A., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000940 · Cited by 3
Hypoglycemia in the Elderly with Diabetes: A Growing Problem with Emerging Solutions
Grajower, M. M. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0182 · Cited by 3
Novodvorský, P., Bernjak, A., Robinson, E. J., Iqbal, A., Macdonald, I. A., Jacques, R., Marques, J. L. B., Sheridan, P. J., & Heller, S. R. (2018) · Diabetic Medicine · doi:10.1111/dme.13650 · Cited by 4
Self-citationHypoglycaemia associated with critical illness and hormone deficiencies: a narrative review
Fernandez, C. J., Rajgopal, R. K., & Pappachan, J. M. (2021) · Journal of Laboratory and Precision Medicine · doi:10.21037/jlpm-2020-ash-01 · Cited by 3
van Dongen, L. H., de Goede, P., Møller, S., Eroglu, T. E., Folke, F., Gislason, G., Blom, M. T., Elders, P. J. M., Torp-Pedersen, C., & Tan, H. L. (2021) · Resuscitation Plus · doi:10.1016/j.resplu.2021.100167 · Cited by 3
“…with DM have a 2–3 fold increased risk for OHCA, 13–15 and previous studies have shown that DM is associated with changes in the temporal patterns of various parameters that impact on the occurrence of cardiac arrhythmias, e.g., 16,17 blood pressure, 18,19 hypoglycaemia, 20 and QTc duration.”
Rydosz, A. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99887-1.00001-7 · Cited by 4
Algorithmen und Verfahrensanweisungen in der Notfallmedizin – Chancen und Risiken
Bathe, J. (2022) · Notarzt · doi:10.1055/a-1646-8960 · Cited by 3
Positionspapier Herzinsuffizienz und Diabetes
Schütt, K. S., Aberle, J., Bauersachs, J. K., Birkenfeld, A. L., Frantz, S., Ganz, M., Jacob, S., Kellerer, M., Leschke, M., Liebetrau, C., et al. (2022) · Die Kardiologie · doi:10.1007/s12181-022-00562-4 · Cited by 3
Makrilakis, K., Stathi, C., Vlahodimitris, I., Kalopita, S., Thomakos, P., Konstantopoulos, P. S., Perrea, D. N., Katsilambros, Ν., & Liatis, S. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.08.005 · Cited by 5
Corchuelo, J. C., Guerrero‐Pérez, F., de la Jordana, P. G.-S., & Pérez-Maraver, M. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.06.007 · Cited by 4
Abobarin-Adeagbo, A., Wienke, A., Girndt, M., & Pliquett, R. U. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00613-4 · Cited by 3
“The reason for this lack of benefit or even excess mortality seen, may relate to hypoglycemia, which correlates with the occurrence of ventricular arrhythmias [3] and bradycardia [4].”
BackgroundТрухан, Д. И. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-14-104-109 · Cited by 3
Tian, K., Ang, L. C., Choudhary, P., Xin, X., Bee, Y. M., Goh, S., & Teh, M. M. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2065143 · Cited by 3
Krentz, A. J., & Rodriguez‐Araujo, G. (2017) · Pharmaceutical Medicine · doi:10.1007/s40290-017-0209-3 · Cited by 3
Pereira, C. A., Almeida, R., & Dores, J. M. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.150 · Cited by 2
Hirose, T., Odawara, M., Matsuhisa, M., Koshida, R., Senda, M., Tanaka, Y., & Terauchi, Y. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108647 · Cited by 3
“[4] Chow E, Bernjak A, Williams S, Fawdry RA, Hibbert S, Freeman J, et al.”
BackgroundMezquita‐Raya, P., Reyes‐García, R., de Torres-Sánchez, A., Matarín, M. G., Cepero-García, D., & de Isla, L. P. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.01.024 · Cited by 2
Sullivan, A. J., Wragg, A., & Rathod, K. S. (2025) · Clinical Medicine · doi:10.1016/j.clinme.2025.100513 · Cited by 5
“20 Specific glucose-lowering therapies with benefit in CVD SGLT2-I were originally designated as a glucose-lowering therapy; however, they have also demonstrated significant benefit in improving cardiovascular outcomes in people with T2DM and those without.”
Demir, E., Nazım, A. T. A., Süzen, B., Yedikardaslar, H. D., Gokkusu, S., Ozsari, L., & Akkan, T. (2026) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s572696 · Cited by 2
“3 Hypoglycemia, particularly in T2DM, was revealed to increase the risk of cardiac arrhythmias, 51 potentially leading to incapacitation and subsequent loss of unconsciousness.”
The Cardiovascular Effects of Acute and Chronic Hypoglycemia
Dintakurti, A., Parikh, M. A., Silver, R., Frishman, W. H., & Peterson, S. J. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001114 · Cited by 2
Improved All Cause and Cardiovascular Mortality and Morbidity by Empagliflozin: Too Good to Be True!
Kabadi, U. M. (2016) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2016.62013 · Cited by 2
Severe hypoglycemia and cardiovascular disease
Tak, S., & Jain, A. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100357 · Cited by 2
Tian, K., Ang, L. C., Choudhary, P., Choo, J. C. J., Bee, Y. M., Goh, S., & Teh, M. M. (2024) · Diabetic Medicine · doi:10.1111/dme.15438 · Cited by 2
Metadata
- Authors
- Chow, E., Bernjak, A., Williams, S., Fawdry, R. A., Hibbert, S., Freeman, J., Sheridan, P. J., & Heller, S. R.
- Affiliations
- University of Sheffield (GB)
- Corresponding author
- Heller, Simon R.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-04-12
- Volume
- 63
- Issue
- 5
- Pages
- 1738-1747
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2042767418
- Cited by
- 403
- References
- 46
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 19 · 2023: 25 · 2022: 30 · 2021: 40 · 2020: 33 · 2019: 25 · 2018: 51 · 2017: 40 · 2016: 41 · 2015: 44 · 2014: 8
- FWCI
- 35.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0611-10248, ACF-2008-04-002, BRF-2011-004)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypoglycemia, cardiac arrhythmias, type 2 diabetes, cardiovascular risk, nocturnal hypoglycemia, bradycardia, cardiac repolarization, QT interval, heart rate variability, insulin-treated patients, cardiovascular mortality, tight glycemic control, Holter monitoring
- MeSH terms
- Aged, Arrhythmias, Cardiac, Autonomic Nervous System, Blood Glucose, Diabetes Mellitus, Type 2, Female, Heart, Heart Rate, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Middle Aged, Risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.